Table 4.
Group A VISPO – Oral N = 18 n (%) | Group B Placebo – Oral N = 19 n (%) | Group C VISPO – Topical N = 18 n (%) | Group D Placebo – Topical N = 18 n (%) | p-value (A vs B) | p-value (C vs D) | |
---|---|---|---|---|---|---|
The area of thinning hair | ||||||
Decreased | 0 (0) | 1 (5.26) | 0 (0) | 1 (5.56) | 0.170‡ | 0.597‡ |
Increased | 6 (33.33) | 2 (10.53) | 2 (11.11) | 2 (11.11) | ||
No change | 12 (66.67) | 16 (84.21) | 16 (88.89) | 15 (83.33) | ||
The amount of hair covering the scalp | ||||||
Decreased | 0 (0) | 0 (0) | 1 (5.56) | 1 (5.56) | 0.092‡ | 0.833‡ |
Increased | 6 (33.33) | 2 (10.53) | 1 (5.56) | 2 (11.11) | ||
No change | 12 (66.67) | 17 (89.47) | 16 (88.89) | 15 (83.33) | ||
The quality of existing hair in terms of thickness and hair shaft appearance | ||||||
Decreased | 0 (0) | 1 (5.26) | 1 (5.56) | 1 (5.56) | 0.022‡* | 0.833‡ |
Increased | 9 (50) | 2 (10.53) | 1 (5.56) | 2 (11.11) | ||
No change | 9 (50) | 16 (84.21) | 16 (88.89) | 15 (83.33) |
Note: ‡Chi square test; *p<0.05.